1. Home
  2. ORIS vs NMTC Comparison

ORIS vs NMTC Comparison

Compare ORIS & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ORIS

Oriental Rise Holdings Limited Ordinary Shares

HOLD

Current Price

$1.49

Market Cap

41.2M

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$0.86

Market Cap

45.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORIS
NMTC
Founded
2014
2009
Country
China
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.2M
45.5M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
ORIS
NMTC
Price
$1.49
$0.86
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$2.23
AVG Volume (30 Days)
631.8K
370.9K
Earning Date
04-30-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$12,317,000.00
$12,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$32.08
P/E Ratio
$198.58
N/A
Revenue Growth
N/A
250.35
52 Week Low
$1.11
$0.40
52 Week High
$45.60
$1.39

Technical Indicators

Market Signals
Indicator
ORIS
NMTC
Relative Strength Index (RSI) 64.43 56.03
Support Level $1.34 $0.85
Resistance Level $1.87 $0.94
Average True Range (ATR) 0.20 0.08
MACD 0.01 -0.00
Stochastic Oscillator 44.74 53.38

Price Performance

Historical Comparison
ORIS
NMTC

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: